Cargando…
Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype
PURPOSE: Colorectal cancer (CRC) is a heterogeneous disease that can be classified into distinct molecular subtypes. The aims of this study were 1) to compare claudin (CLDN) gene expression in CRC samples and normal colon mucosa, and then in the different CRC molecular subtypes, and 2) to assess the...
Autores principales: | Cherradi, Sara, Martineau, Pierre, Gongora, Céline, Del Rio, Maguy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389001/ https://www.ncbi.nlm.nih.gov/pubmed/30863148 http://dx.doi.org/10.2147/CMAR.S188192 |
Ejemplares similares
-
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
por: Cherradi, S., et al.
Publicado: (2017) -
Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment
por: Tosi, Diego, et al.
Publicado: (2018) -
Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells
por: Denis, Vincent, et al.
Publicado: (2022) -
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019) -
Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype
por: Kang, Han Sung, et al.
Publicado: (2011)